Aamaxan Transport Group, Inc.

$0.00-0.00%($-0.00)
TickerSpark Score
37/100
Weak
20
Profitability
60
Growth
36
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AAXT research report →

52-Week Range0% of range
Low $0.00
Current $0.00
High $0.00

Companywww.aamaxan.com

Aamaxan Transport Group, Inc. manufactures medical products that are used during hemodialysis therapy. The company was founded as Shanghai Medical Technology Co.

CEO
Chen Zhong
IPO
2023
Employees
70
HQ
US

Price Chart

+0.00% · this period
$0.00$0.00$0.00May 16Nov 14May 18

Valuation

Market Cap
$1.60K
P/E
0.00
P/S
0.00
P/B
0.00
EV/EBITDA
-0.05
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
54.17%
ROIC
0.00%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-31,418 · -3.24%
EPS
$0.00 · 100.00%
Op Income
$31.42K
FCF YoY
27.79%

Performance & Tape

52W High
$0.00
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
9.48
Avg Volume
1.068

Get TickerSpark's AI analysis on AAXT

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our AAXT Coverage

We haven't published any research on AAXT yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate AAXT Report →

Similar Companies